Phosphoinositide 3-kinase in health and disease Volume 1

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Disgrifiad llawn

Manylion Llyfryddiaeth
Awdur Corfforaethol: SpringerLink (Online service)
Awduron Eraill: Rommel, Christian, Vanhaesebroeck, Bart, Vogt, Peter K.
Fformat: Electronic Resource
Iaith:English
Cyhoeddwyd: Berlin, Heidelberg Springer 2011.
Cyfres:Current Topics in Microbiology and Immunology 346
Pynciau:
Mynediad Ar-lein:Available for University of the Philippines Diliman via SpringerLink. Click here to access